- Home
- ETON vs MRVI Comparison
ETON vs MRVI Comparison
Compare ETON & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ETON | MRVI |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ETON | MRVI |
|---|---|---|
| Price | $55.35 | $7.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 9 |
| Target Price | ★ $71.00 | $7.83 |
| AVG Volume (30 Days) | 487.3K | ★ 2.4M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.29 |
| EPS | ★ 0.41 | N/A |
| Revenue | $79,950,000.00 | ★ $185,743,000.00 |
| Revenue This Year | $88.01 | $14.01 |
| Revenue Next Year | $49.11 | $6.20 |
| P/E Ratio | $133.54 | ★ N/A |
| Revenue Growth | ★ 104.94 | N/A |
| 52 Week Low | $14.27 | $2.55 |
| 52 Week High | $66.37 | $9.42 |
Technical Indicators
Market Signals| Indicator | ETON | MRVI |
|---|---|---|
| Relative Strength Index (RSI) | 48.69 | 49.94 |
| Support Level | $53.60 | $5.54 |
| Resistance Level | $60.60 | $7.60 |
| Average True Range (ATR) | 3.45 | 0.43 |
| MACD | -0.32 | -0.03 |
| Stochastic Oscillator | 54.78 | 25.36 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.